Search Results 721-730 of 16649 for CLL

  1. Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer - Mayo Clinic

    The purpose of this study is to explore the detection of circulating tumor DNA, soluble immune markers, and the evaluation of peripheral blood mononuclear cells ...

  2. A Study of the Effectiveness and Safety of CTL019 in Adult Patients with Diffuse Large B-Cell Lymphoma - Mayo Clinic

    The purpose of this study is to determine the efficacy and safety of CTL019 in adult patients with relapsed or resistant diffuse large B-cell lymphoma.

  3. Publications - Ray Guo, M.D., Ph.D. - Mayo Clinic

    ... CLL patients: a mechanistic study with clinical implications. Br J Cancer. 2024 Aug; 131 (3):589-600 Epub 2024 June 17. View PubMed; Khuong JV, Guo R, Nguyen ...

  4. Waldenstrom macroglobulinemia - Doctors and departments - Mayo Clinic

    What are the best treatment for CLL? Is CAR T cell therapy an option? 11 Replies Sat, Oct 19, 2024. See more discussions. Related. Products & Services. A Book ...

  5. Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer - Mayo Clinic

    About this study. The purpose of these phase I/II trial studies is to analyze the side effects and best dose of liposomal irinotecan and rucaparib when ...

  6. Clinical trials - Oncology (Medical)

    The standard treatment for locally advanced rectal cancer involves chemotherapy and radiation, known as 5FUCMT, (the chemotherapy drugs ...

  7. A Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of various therapies in patients with Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and ...

  8. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    ... chronic lymphocytic leukemia/small lymphocytic lymphoma (Richter transformation). Subjects with prior history of malignancies, other than aggressive R/R NHL ...

  9. Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC) - Mayo Clinic

    This is a trial of AGS-003, which is being studied as a possible treatment for Advanced Renal Cell Carcinoma. The purpose of this study is to determine whether ...

  10. Acute myelogenous leukemia - Doctors and departments - Mayo Clinic

    My Bone Marrow Transplant (BMT/SCT) story: Will you share yours? 399 Replies Sat, Jun 15, 2024. gerryk · CLL - newly diagnosed. 96 Replies Sat, Jun 15, 2024.